ZEB2 and SLUG are mostly considered to be pro‐proliferative and pro‐differentiative markers, not involved in the EMT process in melanoma) and revealed a pattern showing only minimal changes (Fig. 3B). This evidence concerns the gene ZEB2 and melanoma.